665 related articles for article (PubMed ID: 19377047)
21. Lung transplantation affects expression of the chemokine receptor type 4 on specific T cell subsets.
Paantjens AW; van de Graaf EA; Kwakkel-van Erp JM; Hoefnagel T; van Kessel DA; van den Bosch JM; Otten HG
Clin Exp Immunol; 2011 Oct; 166(1):103-9. PubMed ID: 21910727
[TBL] [Abstract][Full Text] [Related]
22. STCP-1 (MDC) CC chemokine acts specifically on chronically activated Th2 lymphocytes and is produced by monocytes on stimulation with Th2 cytokines IL-4 and IL-13.
Andrew DP; Chang MS; McNinch J; Wathen ST; Rihanek M; Tseng J; Spellberg JP; Elias CG
J Immunol; 1998 Nov; 161(9):5027-38. PubMed ID: 9794440
[TBL] [Abstract][Full Text] [Related]
23. Release of both CCR4-active and CXCR3-active chemokines during human allergic pulmonary late-phase reactions.
Bochner BS; Hudson SA; Xiao HQ; Liu MC
J Allergy Clin Immunol; 2003 Nov; 112(5):930-4. PubMed ID: 14610482
[TBL] [Abstract][Full Text] [Related]
24. The CC chemokines MDC and TARC induce platelet activation via CCR4.
Abi-Younes S; Si-Tahar M; Luster AD
Thromb Res; 2001 Feb; 101(4):279-89. PubMed ID: 11248289
[TBL] [Abstract][Full Text] [Related]
25. Differential expression of Th2 chemokine receptors on T cells from atopic and nonatopic asthmatics in response to Der p 1-pulsed dendritic cells.
Maneechotesuwan K; Wongkajornsilp A; Huabprasert S; Kasetsinsombat K; Suthumansami T
J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S62-70. PubMed ID: 20364559
[TBL] [Abstract][Full Text] [Related]
26. The CCR4 as a novel-specific molecular target for immunotherapy in Hodgkin lymphoma.
Ishida T; Ishii T; Inagaki A; Yano H; Kusumoto S; Ri M; Komatsu H; Iida S; Inagaki H; Ueda R
Leukemia; 2006 Dec; 20(12):2162-8. PubMed ID: 17039235
[TBL] [Abstract][Full Text] [Related]
27. Macrophage-derived chemokine and EBI1-ligand chemokine attract human thymocytes in different stage of development and are produced by distinct subsets of medullary epithelial cells: possible implications for negative selection.
Annunziato F; Romagnani P; Cosmi L; Beltrame C; Steiner BH; Lazzeri E; Raport CJ; Galli G; Manetti R; Mavilia C; Vanini V; Chantry D; Maggi E; Romagnani S
J Immunol; 2000 Jul; 165(1):238-46. PubMed ID: 10861057
[TBL] [Abstract][Full Text] [Related]
28. TARC, a CC chemokine, is frequently expressed in classic Hodgkin's lymphoma but not in NLP Hodgkin's lymphoma, T-cell-rich B-cell lymphoma, and most cases of anaplastic large cell lymphoma.
Peh SC; Kim LH; Poppema S
Am J Surg Pathol; 2001 Jul; 25(7):925-9. PubMed ID: 11420464
[TBL] [Abstract][Full Text] [Related]
29. Accumulation of CCR4-expressing CD4+ T cells and high concentration of its ligands (TARC and MDC) in bronchoalveolar lavage fluid of patients with eosinophilic pneumonia.
Katoh S; Fukushima K; Matsumoto N; Matsumoto K; Abe K; Onai N; Matsushima K; Matsukura S
Allergy; 2003 Jun; 58(6):518-23. PubMed ID: 12757454
[TBL] [Abstract][Full Text] [Related]
30. CC chemokine receptor (CCR)3/eotaxin is followed by CCR4/monocyte-derived chemokine in mediating pulmonary T helper lymphocyte type 2 recruitment after serial antigen challenge in vivo.
Lloyd CM; Delaney T; Nguyen T; Tian J; Martinez-A C; Coyle AJ; Gutierrez-Ramos JC
J Exp Med; 2000 Jan; 191(2):265-74. PubMed ID: 10637271
[TBL] [Abstract][Full Text] [Related]
31. Defucosylated anti-CCR4 monoclonal antibody exercises potent ADCC-mediated antitumor effect in the novel tumor-bearing humanized NOD/Shi-scid, IL-2Rgamma(null) mouse model.
Ito A; Ishida T; Yano H; Inagaki A; Suzuki S; Sato F; Takino H; Mori F; Ri M; Kusumoto S; Komatsu H; Iida S; Inagaki H; Ueda R
Cancer Immunol Immunother; 2009 Aug; 58(8):1195-206. PubMed ID: 19048251
[TBL] [Abstract][Full Text] [Related]
32. Increased CCR4 expression in cutaneous T cell lymphoma.
Ferenczi K; Fuhlbrigge RC; Pinkus J; Pinkus GS; Kupper TS
J Invest Dermatol; 2002 Dec; 119(6):1405-10. PubMed ID: 12485447
[TBL] [Abstract][Full Text] [Related]
33. Dominance of CCL22 over CCL17 in induction of chemokine receptor CCR4 desensitization and internalization on human Th2 cells.
Mariani M; Lang R; Binda E; Panina-Bordignon P; D'Ambrosio D
Eur J Immunol; 2004 Jan; 34(1):231-40. PubMed ID: 14971049
[TBL] [Abstract][Full Text] [Related]
34. Clonal Th2 cells associated with chronic hypereosinophilia: TARC-induced CCR4 down-regulation in vivo.
de Lavareille A; Roufosse F; Schandené L; Stordeur P; Cogan E; Goldman M
Eur J Immunol; 2001 Apr; 31(4):1037-46. PubMed ID: 11298328
[TBL] [Abstract][Full Text] [Related]
35. CD30 ligand, a member of the TNF ligand superfamily, with growth and activation control CD30+ lymphoid and lymphoma cells.
Gruss H-J ; Herrmann F
Leuk Lymphoma; 1996 Feb; 20(5-6):397-409. PubMed ID: 8833395
[TBL] [Abstract][Full Text] [Related]
36. Skin-versus gut-skewed homing receptor expression and intrinsic CCR4 expression on human peripheral blood CD4+CD25+ suppressor T cells.
Iellem A; Colantonio L; D'Ambrosio D
Eur J Immunol; 2003 Jun; 33(6):1488-96. PubMed ID: 12778466
[TBL] [Abstract][Full Text] [Related]
37. Serum chemokine levels in Hodgkin lymphoma patients: highly increased levels of CCL17 and CCL22.
Niens M; Visser L; Nolte IM; van der Steege G; Diepstra A; Cordano P; Jarrett RF; Te Meerman GJ; Poppema S; van den Berg A
Br J Haematol; 2008 Mar; 140(5):527-36. PubMed ID: 18275430
[TBL] [Abstract][Full Text] [Related]
38. Production of TARC and MDC by naive T cells in asthmatic patients.
Hirata H; Arima M; Cheng G; Honda K; Fukushima F; Yoshida N; Eda F; Fukuda T
J Clin Immunol; 2003 Jan; 23(1):34-45. PubMed ID: 12645858
[TBL] [Abstract][Full Text] [Related]
39. A Th2 chemokine, TARC, produced by keratinocytes may recruit CLA+CCR4+ lymphocytes into lesional atopic dermatitis skin.
Vestergaard C; Bang K; Gesser B; Yoneyama H; Matsushima K; Larsen CG
J Invest Dermatol; 2000 Oct; 115(4):640-6. PubMed ID: 10998136
[TBL] [Abstract][Full Text] [Related]
40. Role of the chemokine receptor CCR4 and its ligand thymus- and activation-regulated chemokine/CCL17 for lymphocyte recruitment in cutaneous lupus erythematosus.
Wenzel J; Henze S; Wörenkämper E; Basner-Tschakarjan E; Sokolowska-Wojdylo M; Steitz J; Bieber T; Tüting T
J Invest Dermatol; 2005 Jun; 124(6):1241-8. PubMed ID: 15955100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
